Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Capital Expenditures (2020 - 2025)

Agilon Health's Capital Expenditures history spans 6 years, with the latest figure at $3.0 million for Q4 2025.

  • For Q4 2025, Capital Expenditures fell 9.12% year-over-year to $3.0 million; the TTM value through Dec 2025 reached $13.2 million, changed 0.07%, while the annual FY2025 figure was $13.2 million, 0.07% changed from the prior year.
  • Capital Expenditures reached $3.0 million in Q4 2025 per AGL's latest filing, down from $3.2 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $4.5 million in Q2 2022 to a low of $178000.0 in Q1 2021.
  • Average Capital Expenditures over 5 years is $3.2 million, with a median of $3.4 million recorded in 2021.
  • Peak YoY movement for Capital Expenditures: plummeted 48.41% in 2021, then skyrocketed 2174.72% in 2022.
  • A 5-year view of Capital Expenditures shows it stood at $3.4 million in 2021, then rose by 2.62% to $3.5 million in 2022, then increased by 12.7% to $3.9 million in 2023, then decreased by 16.94% to $3.3 million in 2024, then fell by 9.12% to $3.0 million in 2025.
  • Per Business Quant, the three most recent readings for AGL's Capital Expenditures are $3.0 million (Q4 2025), $3.2 million (Q3 2025), and $3.2 million (Q2 2025).